Coloplast A/S - Allokering af aktieoptioner
February 09, 2024 10:18 ET
|
Coloplast A/S
Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med Coloplast aktier og tilknyttede værdipapirer I henhold til Markedsmisbrugsforordningen art. 19 skal Coloplast...
Coloplast A/S - Allocation of Share Options
February 09, 2024 10:18 ET
|
Coloplast A/S
Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the...
Coloplast lancerer Peristeen® Light til mennesker med tarmlidelser
February 09, 2024 01:34 ET
|
Coloplast A/S
Det nye produkt til transanal irrigation er designet til at lette hverdagen for mennesker, der har afførings- eller lækageproblemer. Det estimeres, at 10-15% af verdens befolkning lider af...
Coloplast launches Peristeen® Light for people with bowel disorders
February 09, 2024 01:34 ET
|
Coloplast A/S
The new transanal irrigation device is designed to help people facing defecation issues or stool leakage. It is estimated that 10-15% of the world’s population are affected...
Coloplast A/S - Regnskabsmeddelelse, Q1 2023/24
February 09, 2024 01:30 ET
|
Coloplast A/S
Q1 2023/24Delårsrapport, 1. kvartal 2023/241. oktober 2023 – 31. december 2023 Coloplast leverede et solidt 1. kvartal med 8% organisk vækst og en overskudsgrad1) på 28%. Den rapporterede...
Coloplast A/S - Interim Financial Report, Q1 2023/24
February 09, 2024 01:30 ET
|
Coloplast A/S
Q1 2023/24Interim financial results, Q1 2023/241 October 2023 - 31 December 2023 Coloplast delivered a solid Q1 with 8% organic growth and an EBIT margin1) of 28%. Reported...
Coloplast lancerer Biatain® Silicone Fit til sårbehandling og forebyggelse af tryksår i USA
January 31, 2024 10:00 ET
|
Coloplast A/S
Selskabet sigter efter at udvide sin position inden for avanceret sårbehandling ved at introducere en ny sårbandage, der gavner både sundhedspersonale og patienter. ”Vi introducerer nu dette nye...
Coloplast launches Biatain® Silicone Fit for pressure injury prevention and wound management in the US
January 31, 2024 10:00 ET
|
Coloplast A/S
The company aims to expand its position within advanced wound care by introducing a new silicone foam that will benefit both healthcare professionals and patients. “We are now introducing new...
Coloplast A/S - Q1 2023/24 Earnings Release - Invitation for conference call on 9 February 2024 at 11.00am CET
January 19, 2024 04:03 ET
|
Coloplast A/S
Friday, 9 February 2024 at 11.00 - 12.00 CETIn connection with the publication of Coloplast’s interim financial results for Q1 2023/24, to be released same day around 07.30 am CET, Coloplast will host...
Coloplast A/S - Skift af revisor
December 07, 2023 11:29 ET
|
Coloplast A/S
I dag, den 7. december 2023, har Coloplast A/S afholdt ordinær generalforsamling, hvor EY Godkendt Revisionspartnerselskab blev valgt som Coloplast A/S’ revisor i overensstemmelse med forslaget fra...